Guaifenesin
Who holds supplier records for Guaifenesin? 7 organisations hold a current record for Guaifenesin: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), Taiwan (2), China (1) and Germany (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Guaifenesin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/guaifenesin
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Guaifenesin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- DELTA SYNTHETIC CO LTDTaiwanCEPActive DMF 5809 · latest filing Apr 1985
- Granules India LimitedIndiaCEP Company GMP cert on recordActive DMF 14372 · latest filing Aug 1999
- Seven Star Pharmaceutical Co., Ltd.TaiwanCEPActive DMF 16122 · latest filing Sept 2002
- SYNTHOKEM LABS PRIVATE LTDIndiaCEPActive DMF 10413 · latest filing Aug 1993
- Zhejiang Haizhou Pharmaceutical Co., Ltd.ChinaActive DMF 29179 · latest filing Mar 2015
- IndiaCEP
- BIESTERFELD SPEZIALCHEMIE GMBHGermanyCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Guaifenesin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| GRANULES INDIA LIMITED Hyderabad | IN | CEP 2021-332 - Rev 01 Guaifenesin, BPL site | Sept 2025 | — |
| SYNTHOKEM LABS PRIVATE LIMITED Hyderabad | IN | CEP 2019-065 - Rev 01 Guaifenesin, Unit-II | Jan 2025 | — |
| SMILAX LABORATORIES LIMITED Hyderabad | IN | CEP 2024-189 - Rev 00 Guaifenesin | Nov 2024 | — |
| SEVEN STAR PHARMACEUTICAL COMPANY, LTD. New Taipei City | TW | R1-CEP 2008-275 - Rev 04 Guaifenesin | Apr 2021 | — |
| DELTA SYNTHETIC CO., LTD. New Taipei City | TW | R1-CEP 2009-351 - Rev 02 Guaifenesin, Regular, milled | Jun 2020 | — |
| BIESTERFELD SPEZIALCHEMIE GMBH Hamburg | DE | R1-CEP 2002-194 - Rev 03 Guaifenesin | Jun 2018 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (10)
Organisations whose Type II DMFs for Guaifenesin are no longer active. These show a past filing, not current supply.
Show all 10 historical records
- PAN DRUGS LTDInactive DMF 25752, 26324 · filed Sept 2012
- ZHEJIANG JIANFENG HAIZHOU PHARMACEUTICAL CO LTDInactive DMF 22840 · filed May 2009
- NINGBO SMART PHARMACEUTICAL CO LTDInactive DMF 18029 · filed Jan 2005
- BOEHRINGER INGELHEIM CHEMICALS INCInactive DMF 5972, 15507 · filed Jun 2001
- CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDInactive DMF 14234 · filed Jun 1999
- SIANG TA PHARMACEUTICAL CO LTDInactive DMF 10988 · filed Jul 1994
- India · Inactive DMF 9262 · filed Jul 1991
- CHINA NATIONAL CHEMICAL IMPORT AND EXPORT CORPInactive DMF 5423 · filed May 1984
- France · Inactive DMF 4989 · filed Jun 1983
- PEBOC LTDInactive DMF 4866 · filed Mar 1983
Overview
Guaifenesin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL980).
Chemical identity
- IUPAC name
- 3-(2-methoxyphenoxy)propane-1,2-diol
- Canonical SMILES
- COC1=CC=CC=C1OCC(CO)O
- InChIKey
- HSRJKNPTNIJEKV-UHFFFAOYSA-N
- Synonyms
- Amonidron, CVT-2534, Famel, Franolyn chesty, Gecolate, Glycerol guaiacolate, Glyceryl guaiacolate, Guaiacol glyceryl ether, Guaifenesin, Guaifenesina, Guaifenesin component of flowtuss, Guaifenesin component of hycofenix
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Expectorant
- Physiologic effect
- Decreased Respiratory Secretion Viscosity; Increased Respiratory Secretions
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Guaifenesin?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Guaifenesin: DELTA SYNTHETIC CO LTD (Taiwan), Granules India Limited (India), Seven Star Pharmaceutical Co., Ltd. (Taiwan), SYNTHOKEM LABS PRIVATE LTD (India), Zhejiang Haizhou Pharmaceutical Co., Ltd. (China), SMILAX LABORATORIES LTD (India) and BIESTERFELD SPEZIALCHEMIE GMBH (Germany). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Guaifenesin Drug Master Files are active?
DELTA SYNTHETIC CO LTD (DMF 5809), Granules India Limited (DMF 14372), Seven Star Pharmaceutical Co., Ltd. (DMF 16122), SYNTHOKEM LABS PRIVATE LTD (DMF 10413) and Zhejiang Haizhou Pharmaceutical Co., Ltd. (DMF 29179). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Guaifenesin records mean?
10 organisations have only inactive Type II DMFs for Guaifenesin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Guaifenesin have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Guaifenesin on the EDQM register, including GRANULES INDIA LIMITED Hyderabad (IN), SYNTHOKEM LABS PRIVATE LIMITED Hyderabad (IN), SMILAX LABORATORIES LIMITED Hyderabad (IN), SEVEN STAR PHARMACEUTICAL COMPANY, LTD. New Taipei City (TW), DELTA SYNTHETIC CO., LTD. New Taipei City (TW) and BIESTERFELD SPEZIALCHEMIE GMBH Hamburg (DE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Guaifenesin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Guaifenesin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.